baber/WOPTO huggingface dataset:
Patent NZ-554081-A (NZ)
Title: A drilling apparatus having in-line extending wings and driving method thereof
Inventor: LIM BYUNG-DUK
Filed: 2005-09-02
Abstract: A borehole drilling apparatus 10 with in-line extending wings 200, comprising a guide device 100, wings 200 for extending a borehole, and a pilot bit 300, wherein the guide device 100 is configured to be a cylindrical structure through which an air hole 20 is passed along a centre axis thereof; and includes an upper shaft portion, a piston portion and a lower shaft portion, wherein the piston portion is formed on the outer circumferential surface thereof with a plurality of sludge discharging grooves; and the lower shaft portion is formed at the lower surface thereof with spiral projections, the spiral projections each having a curved surface whose radius increases from the centre, and formed at a side thereof with a retaining protrusion and pin 400 engaging means; wherein the extending wing is wholly configured to be a rectangular structure, and is formed at a side thereof with a guide groove for engaging slidably with the curved surface of the spiral projection below the guide device 100; and wherein the pilot bit 300 is configured to have a concave structure in which the lower shaft portion of the guide device 100 and the extending wings 200 are received, the pilot bit 300 being formed at a side thereof with an advancing and retracting window for the extending wing, formed at the inner circumferential surface thereof with a retaining step and pin 400 engagement means for restricting the rotation of the guide device 100 by the retaining protrusion, formed at the lower surface thereof with an air hole 20, and formed at the outer circumferential surface thereof with a plurality of sludge discharging grooves.
Patent NZ-560518-A (NZ)
Title: System and method for using time-distance characteristics in acquistion, processing and imaging of T-CSEM data
Inventor: THOMSEN LEON A
IPC: G01V3/12
Filed: 2006-02-21
Abstract: A method of geophysical exploration of the earth in which an EM survey was acquired that covers a predetermined volume of the earth is provided. The survey includes a number of EM traces, and in which at least the EM traces are used to obtain an image of least a portion of the predetermined volume of the earth. The method includes correcting at least one EM signal trace for at least one of attenuation and dispersion at a number of different frequencies according to at least one parameter "Q" and at least one EM velocity to produce an image of at least a portion of the predetermined volume of the earth, where "Q" is a quality factor related to a transmission of EM signals within the predetermined volume of the earth.
Patent NZ-561157-A (NZ)
Title: Method of controlling acetic acid process
Inventor: LIU LUN-KUANG
IPC: C07C51/00
Filed: 2006-02-07
Abstract: Disclosed is a method of controlling a process for producing acetic acid by carbonylation of methanol or a carbonylatable derivative thereof, comprising the steps of: monitoring the rate of production of the acetic acid under a set of normal operating conditions; reducing the production rate in response to a an unexpected and significant change in operating conditions due to a process disturbance outside of said normal operating conditions requiring a reduction in production rate; after the production rate is reduced, controlling the process at the reduced production rate; and increasing the production rate after said condition change has been addressed until at least the production rate returns to a normal operating range; wherein during the step of increasing the production rate until the production rate returns to a normal operating range, the process is controlled by nonlinear multivariable control based on a model of the process, wherein the controlling of the process is during the severe process disturbance outside of said normal operating conditions and/or during a recovery period after the severe process disturbance outside of said normal operating conditions has been addressed, wherein the unexpected and significant change in operating conditions due to a process disturbance outside of said normal operating conditions requiring a reduction in production rate results from a condition change selected from the group consisting of: (a) a reduction in the supply of carbon monoxide and/or methanol to the reactor in an amount sufficient to require a reduction in production rate greater than experienced during said normal operating conditions; (b) failure of a mechanical pump; (c) loss of heating or cooling capacity; (d) flooding of a downstream purification column; (e) a shortage of storage capacity for acetic acid product; and combinations thereof.
Patent NZ-562537-A (NZ)
Title: 2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as CGRP antagonists
Inventor: MUELLER STEPHAN GEORG
IPC: A61K31/501
Filed: 2006-03-21
Abstract: Disclosed are Calcitonin-Gene-Related Peptide antagonists (CGRP antagonists) of general formula (I), in which B, R1 and R2 are defined as defined in the specification, their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and salts, in addition to the hydrates of their salts, in particular their physiologically compatible salts, with inorganic or organic acids or bases. The disclosure also relates to medicaments containing said compounds, their use and a method for their production.
Patent NZ-567218-A (NZ)
Title: A bicycle safety device
Inventor: CARRUTHERS PETER BAIN
Filed: 2008-04-04
Abstract: A bicycle safety device is disclosed. The bicycle safety device comprises a body, which includes a mounting assembly for mounting the device to a bicycle, an arm, movable between a first position in which the arm extends outwardly and a second position in which the arm extends downwardly and which is movable to a third position, in which the arm extends outwardly to the opposite side. One or more lights are provided at or near the distal end of the arm.
Patent NZ-568071-A (NZ)
Title: Taste improving agent comprising a whey mineral
Inventor: IKEDA KENJI
IPC: A23L11/20
Filed: 2007-06-20
Abstract: Disclosed is a taste improving agent comprising as an active ingredient a whey mineral satisfying all the criteria (a), (b), (c), (d), and (e) below: (a) an ash content in a solid portion of the whey mineral is 25 to 75% by mass; (b) a calcium content in a solid portion of the whey mineral is less than 0.5% by mass; (c) a calcium content in an ash portion of the whey mineral is less than 5% by mass; (d) a lactic acid content in a solid portion of the whey mineral is 1.0% by mass or more; and (e) a pH of an aqueous solution containing 0.1% by mass of a solid portion of the whey mineral is 6.0 to 7.5. Also disclosed is a food, beverage or oral drug comprising a taste improving agent as described above. Further disclosed is the method for producing a food, beverage or oral drug comprising a taste improving agent as described above.
Patent NZ-569605-A (NZ)
Title: A bouillon and/or seasoning tablet containing cereal, vegetable and/or fruit fibers
Inventor: KEHLENBECK VOLKER
IPC: A23L29/262
Filed: 2007-01-24
Abstract: Disclosed herein is a process for the production of a bouillon and/or seasoning tablet and/or cube, which comprises, in total % in weight, 0.5-10% oil, and/or 0-5% fat, binders, salt, between 1-5% of total water, and between 0.5-8% of cereal, vegetable and/or fruit biers, as well as optionally sugar, spices, flavours, taste enhancers, dehydrated vegetables, herb leaves and/or plant extracts, wherein the fibers are wetted with a saturated salt solution by spraying said saturated solution on the fibers, the wetted fibers are then mixed with all other ingredients and the obtained mixture is tableted.
Patent NZ-569669-A (NZ)
Title: Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
Inventor: DUBOIS LAURENT
IPC: A61K31/4188
Filed: 2007-02-01
Abstract: Disclosed is a benzimidizole corresponding to formula (I) in which: Y is an oxygen or sulphur atom; A, P, R1, R2 and R3 are defined in the specification. Also disclosed is a process to prepare said benzimidizole, compositions comprising said benzimidizole and the use of said benzimidizole in the treatment of pain, inflammation, metabolic disorders, urological disorders, gynaecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritis, dermal, ocular or mucosal irritations, herpes, shingles, multiple sclerosis and depression.
Patent NZ-571913-A (NZ)
Title: Tenocyte cell culturing method
Inventor: ZHENG MING HAO
IPC: A61K35/12
Filed: 2007-03-23
Abstract: Disclosed is a tenocyte culture medium comprising insulin and betamethasone. Also disclosed is a method for producing a culture of tenocytes comprising the steps of: (i) providing an isolated tenocyte-containing tissue; (ii) washing and mincing said tenocyte-containing tissue to form explants; and (iii) culturing said explants in the presence of a tenocyte culture medium comprising insulin and betamethasone to yield free tenocytes; wherein at least 90% of the cells present in the culture are tenocytes.
Patent NZ-572147-A (NZ)
Title: N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
Inventor: MINUCCI SAVERIO
IPC: A61K31/4468
Filed: 2007-03-30
Abstract: Disclosed are N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds of formula (I) as histone deacetylase inhibitors (HDACs) for the treatment of diseases linked to the deregulation of histone deacetylases activity such as cancer.
Patent NZ-587797-A (NZ)
Title: Use of alternan as texturizing agent in foodstuffs and cosmetics
Inventor: FROHBERG CLAUS
IPC: A23L33/20
Filed: 2009-03-06
Abstract: The disclosure relates to the use of alternan as texturizing agent, particularly as fat or oil replacer in foodstuffs preparations; a homogeneous composition comprising alternan, water and a fat or oil; the use of the homogeneous composition as texturizing agent in foodstuffs or cosmetic preparations; and foodstuffs comprising alternan as texturizing agent or a homogeneous composition comprising alternan. The specification also describes the use of alternan in cosmetic preparations.
Patent NZ-590286-A (NZ)
Title: Phosphate and sulphate salts of 6-{ 2-[1-(6-methyl-3-pyrazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole
Inventor: RYAN JANE
IPC: A61P31/16
Filed: 2009-05-27
Abstract: The disclosure relates to antiviral agents, in particular to acid addition salts of 6-{ 2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole which are useful in the treatment of infections caused by Picornaviridae, such as human rhinovirus (HRV) and methods for their preparation. Particularly disclosed are acid addition salts namely: 6-{ 2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole bis-dihydrogenphosphate salt (1:2) and 6-{ 2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole sulfate salt (1:1). These salts are useful in the treatment of picornavirus infections, and are especially suitable for use in the treatment of HRV, and are also applicable to other viruses of the picornavirus family.
Patent NZ-592653-A (NZ)
Title: Priming system and method for dialysis systems
Inventor: HERING MARTIN
IPC: A61M1/16
Filed: 2009-10-07
Abstract: 592653 Disclosed is a dialysis treatment system capable of operating in a priming mode and a treatment mode to provide better treatment of a patient's blood. The dialysis treatment system comprises a housing defining a cavity, the cavity receives a manifold. The manifold comprises a plastic substrate comprising a first layer and a second layer, a first flow path defined by a first surface of the first layer and a first surface of the second layer, a second flow path defined by a first surface of the first layer and a first surface of the second layer. A valve is in fluid communication with both the first flow path and the second flow path wherein the valve has a first state and a second state and wherein, when in the first state, the first flow path and second flow path are in fluid isolation and when in the second state, the first flow path and second flow path are in fluid communication. A diaphragm is moulded into the manifold and positioned over the valve. A valve interface is physically attached to the housing, wherein the valve interface is configured to apply pressure to, or remove pressure from, the diaphragm to cause the valve to switch between the first state and the second state. The manifold further comprises a first pump outlet, wherein the first pump outlet receives blood being pumped by a first pump, and a second pump outlet, wherein the second pump outlet receives dialysate being pumped by a second pump. The valve is located adjacent the first pump outlet and the second pump outlet. The valve is in the first state, the first pump outlet and second pump outlet are in fluid isolation from each other.
Patent NZ-599393-A (NZ)
Title: Post driver extractor
Inventor: TRETHEWEY REGINALD
IPC: A01G17/16
Filed: 2010-09-21
Abstract: 599393 A device for both driving and extracting a post such as a wooden stake, metal standard or picket is disclosed. The device comprises a hollow barrel (1) with a closed end and an open end for receiving the post. Two longitudinal handles (2A, 2B) extend along the barrel (1) and at least one of the handles (2B) is pivotally fixed at the closed end and releasably secured with a fastener (6) at the other end. The pivotally fixed handle (2B) is used to facilitate driving of the post or can be released to act as a lever for extracting the post. Methods of driving and extracting a post using the device are also disclosed.
Patent NZ-600155-A (NZ)
Title: An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
Inventor: CHENG SENG
IPC: C07D405/06
Filed: 2010-11-24
Abstract: The hemitartrate salt of a compound represented by the structural formula I (GENZ 112638, eliglustat tartrate), which may be used in pharmaceutical applications, is disclosed. Particular single crystalline forms of the hemitartrate salt are characterized by a variety of properties and physical measurements. As well, methods of producing crystalline forms of the hemitartrate salt, and using it to inhibit glucosylceramide synthase or lowering glycosphingolipid concentrations in subjects to treat a number of diseases such as Gaucher disease and Fabry disease, are also discussed. Pharmaceutical compositions are also described.
Patent NZ-603488-A (NZ)
Title: Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
Inventor: WILLIAMSON ROBERT ANTHONY
IPC: C07K16/10
Filed: 2011-07-08
Abstract: Disclosed is an anti-RSV antibody comprising CDR sequences of: CDRH1: GFTFSGHTIA or GHTIA CDRH2: WVSTNNGNTEYAQKIQG CDRH3: EWLVMGGFAFDH CDRL1: GANNIGSQNVH CDRL2: DDRDRPS CDRL3: QVWDSSRDQAVI Also disclosed is the use of said anti-RSV antibody for formulation of a medicament for treating or inhibiting one or more symptoms of a RSV infection, or for preventing a RSV infection.
Patent NZ-622711-A (NZ)
Title: Cd27l antigen binding proteins
Inventor: DELANEY JOHN M
IPC: C07K16/28
Filed: 2012-09-20
Abstract: Disclosed is a CD27L antigen binding protein having a light chain variable domain comprising an LCDR1 having no more than three amino acid additions, deletions, or substitutions from the LCDR1 sequence set forth in RSSQSLLNSNGYNYLD; an LCDR2 having no more than two amino acid additions, deletions, or substitutions from the LCDR2 sequence set forth in LGSYRAS; and an LCDR3 having no more than two amino acid additions, deletions, or substitutions from the LCDR3 sequence set forth in IQTLQTPFT; and a heavy chain variable domain comprising an HCDR1 having no more than one amino acid addition, deletion, or substitution from the HCDR1 sequence set forth in NYGIH; an HCDR2 having no more than three amino acid additions, deletions, or substitutions from the HCDR2 sequence set forth in VIWYDGSNKYYADSVKG; and an HCDR3 having no more than three amino acid additions, deletions, or substitutions from the HCDR3 sequence set forth in DGGYSGYDSGFDY.
Patent NZ-624722-A (NZ)
Title: Novel 2h-indazoles as ep2 receptor antagonists
Inventor: TER LAAK ANTONIUS
IPC: C07D417/14
Filed: 2012-11-26
Abstract: The present disclosure relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2- receptor. An example of the compound is 2-{ [1-(4-cyano-2-fluorobenzoyl)piperidin-4-yl]methyl} -N-(2-methoxyethyl)-4-methyl-2H-indazol-S-carboxamide.
Patent NZ-701253-A (NZ)
Title: Planing hull for rough seas
Inventor: LOUI STEVEN C H
IPC: B63B1/32
Filed: 2013-01-29
Abstract: The disclosed watercraft hull has a flat pad keel whose beam tapers towards the bow and its beam at the transom is 15% to 25% of the hull’s beam at its chines. The hull is symmetric about its centerline, has a fine entry bow, a transom, and a pair of hard chines. Between the pad keel and the chines the hull has at least one pair of generally flat panels referred to herein as longitudinal steps having approximately 0 degrees of deadrise forming planing surfaces symmetrically located about the hull centerline. The hull also includes at least one pair of ultra high deadrise panels, outboard of and adjacent to the pad keel, located symmetrically about the hull centerline, and extending therefrom to the flat planing panels above them. The ultra high deadrise panels have a minimum average deadrise of approximately 50 degrees measured along their length. Additional flat planing surface structures having approximately 0° deadrise may be installed longitudinally on the hull between the pad keel and the hard chine such that the vertical offset between any two planing surfaces along the hull’s stagnation line does not exceed approximately six inches. High deadrise panels or fillets with deadrise angles of between about 20 and 35 degrees may be included in the hull outboard of and adjacent to the ultra high deadrise panels and located symmetrically about the hull centerline. The fillets are tapered into wedge shapes at their forward ends to blend into the adjacent ultra high deadrise and flat planing panels.
Patent NZ-704675-A (NZ)
Title: Methods and apparatus to assemble actuators
Inventor: ADAMS DANIEL MARTIN
IPC: F16K31/163
Filed: 2013-08-19
Abstract: Methods and apparatus to assemble actuators are described. An example method includes positioning a biasing element in a cavity defined by a housing of an actuator such that the biasing element is in an uncompressed state and at least a portion of the biasing element is to extend outside of the cavity beyond an end defined by the housing; compressing the biasing element to a compressed state until the portion of the biasing element extending outside of the cavity is positioned inside the cavity; coupling a cover to the end of the housing to capture the biasing element in the cavity; and maintaining the biasing element in the compressed state during the coupling such that the biasing element does not engage the cover.
Patent NZ-706717-A (NZ)
Title: Tert-butyl n-[2-{ 4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2h)-yl]-3,5-difluorophenyl} ethyl]-l-alaninate or a salt, hydrate or solvate thereof
Inventor: PINTAT STEPHANE
IPC: C07D213/78
Filed: 2013-10-15
Abstract: The present invention provides a compound which is: tert-butyl N-[2-{ 4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl} ethyl)-L-alaninate or a salt, hydrate or solvate thereof. The present invention also provides a pharmaceutical composition comprising the compound together with one or more pharmaceutically acceptable carriers and/or excipients. The compound and composition are useful for inhibiting the activity of a p38 MAP kinase enzyme. As such they may be used in the treatment of a autoimmune or inflammatory disease, or a cell proliferative disease. In addition, the invention provides an acid produced by hydrolysis of the ester group of the compound of the invention. The acid is N-[2-{ 4-[6-amino-5-(2,4-difluorobenzoyl)-2- oxopyridin-1(2H)-yl]-3,5-difluorophenyl} ethyl)-L-alanine.
Patent NZ-708031-A (NZ)
Title: Pyridine derivative
Inventor: TAKAHASHI YOSHIMASA
IPC: C07D409/14
Filed: 2013-11-13
Abstract: Provided is a pyridine derivative represented by formula (I), a prodrug thereof, a pharmaceutically acceptable salt of the pyridine derivative or the prodrug, or a solvate of the pyridine derivative, the prodrug or the pharmaceutically acceptable salt, which is useful for treatment or prophylaxis of diseases associated with URAT1 such as gout, hyperuricemia, hypertension, kidney diseases such as interstitial nephritis, diabetes, arteriosclerosis and Lesch-Nyhan syndrome.
Patent NZ-711558-A (NZ)
Title: Fire retarding systems and protective layers or coatings
Inventor: MCKEE JOHN WASON
IPC: C09K21/08
Filed: 2014-08-29
Abstract: Disclosed is a multilayer coating for a substrate such as a photovoltaic module or cell having flame retardant capability, the coating comprising two or more carrier or polymer layers, wherein at least one layer of the two or more carrier or polymer layers is a layer comprising a halogenated material and at least one other layer of the two or more carrier or polymer layers comprises at least one synergist. Also disclosed are substrates coated with the coating, a method of coating a substrate, and a method of manufacturing the coating.
Patent NZ-712440-A (NZ)
Title: Subcutaneous administration of adamts13
Inventor: PLAIMAUER BARBARA
IPC: A61P7/02
Filed: 2014-03-13
Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
Patent NZ-721845-A (NZ)
Title: Card game monitoring system
Inventor: SHIGETA YASUSHI
IPC: G07F17/32
Filed: 2015-01-16
Abstract: The present invention is directed to a card game monitoring system for enhancing security of Baccarat games at entertainment places such as casinos. The card game monitoring system for a Baccarat game comprises a table (1), a card shooter apparatus (5), a camera system (8) and a control unit (10). The control unit (10) is is connected with the camera system, and is configured to determine whether the winning hand of a game is the Banker’s or Player’s hand according to the game rules and the numbers of the cards read by the card shooter apparatus (5). The control unit (10) is further configured to verify that the bets which are paid-off and moved to the bettors with the winning hands after each game has ended based on the movements detected by the camera system.
Patent NZ-722669-A (NZ)
Title: Topical antiparasitic delivery systems for animals
Inventor: PATE JAMES
IPC: A61P33/10
Filed: 2015-01-20
Abstract: The invention is a pour-on antiparasitic formulation. The pour-on formulation utilizes one or more polymers (water insoluble with or without water soluble) in the range of about 5 to about 40% w/w, one or more solvents in the range of about 50 to about 94% w/w, with or without additive (e.g., isopropanol or ethanol) in the range of about 5 to about 30% w/w, and optionally a plasticizer in the range of about 0.5 to about 25% w/w. The pour-on antiparasitic formulation features limited spreading when applied to animals (cattle, sheep, dogs and the like). The pour-on antiparasitic formulation further partially evaporates, leaving a water resistant polymer matrix that diffuses at least one active ingredient to the animal’s skin.